SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-18-000062
Filing Date
2018-05-09
Accepted
2018-05-09 11:10:59
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jnce0331201810-q.htm 10-Q 990276
2 EXHIBIT 31.1 jnce03312018exhibit311.htm EX-31.1 10662
3 EXHIBIT 31.2 jnce03312018exhibit312.htm EX-31.2 10670
4 EXHIBIT 32.1 jnce03312018exhibit321.htm EX-32.1 11712
  Complete submission text file 0001640455-18-000062.txt   5061902

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jnce-20180331.xml EX-101.INS 966688
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20180331.xsd EX-101.SCH 41546
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20180331_cal.xml EX-101.CAL 60940
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20180331_def.xml EX-101.DEF 222527
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20180331_lab.xml EX-101.LAB 530829
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20180331_pre.xml EX-101.PRE 336371
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 18817244
SIC: 2836 Biological Products, (No Diagnostic Substances)